Ying Wang

发表

Heparin- and basic fibroblast growth factor-incorporated stent: a new promising method for myocardial revascularization.

Xiao-cheng Liu, G. He, Jian Zhao, 2010, The Journal of surgical research.

Transmyocardial drilling revascularization combined with heparinized bFGF-incorporating stent activates resident cardiac stem cells via SDF-1/CXCR4 axis.

Jing Liu, Ye Zhao, T. Gu, 2012, Experimental cell research.

Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.

Cun-xian Song, Xiao-cheng Liu, Jian Zhao, 2009, Texas Heart Institute Journal.

Establishment of TUSMi005-A, an induced pluripotent stem cell (iPSC) line from a 32-year old Chinese Han patient with Bipolar Disorder (BD).

H. Qiu, Jian Zhao, Ying Wang, 2018, Stem cell research.

Establishment of TUSMi004-A, an induced pluripotent stem cell (iPSC) line from a 32-year old Chinese Han patient with Obsessive-Compulsive Disorder (OCD).

Jian Zhao, Ying Wang, Hongxiang Yu, 2018, Stem cell research.

Generation of an induced pluripotent stem cell line (SIAISi009-A) from a 60-year-old Chinese Han female with mild cognitive impairment (MCI) having two copies of APOE4/4 allele.

Yulei Deng, Jing-hui Guo, Jian Zhao, 2021, Stem cell research.

Generation of a human-derived induced pluripotent stem cell line (SIAISi012-A) from an 82-year-old healthy Chinese Han male.

Jing-hui Guo, Jiumei Cao, Jian Zhao, 2021, Stem cell research.

A new transmyocardial degradable stent combined with growth factor, heparin, and stem cells in acute myocardial infarction.

Cun-xian Song, Xiao-cheng Liu, Qin Yang, 2009, Cardiovascular research.

Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation.

Jinghua Hu, Jing Zhang, Jian Zhao, 2019, Stem cell research.

Generation of an induced pluripotent stem cell line (SIAISi003-A) from a 79-year-old patient with Alzheimer's disease having APOE3/4 genetic background.

Jian Zhao, Ying Wang, Weihao Di, 2020, Stem cell research.

Establishment of SIAISi002-A, an induced pluripotent stem cell (iPSC) line from 39-year old healthy female donor with a family history of Alzheimer's disease (AD) and two copies of APOE4 gene.

Yulei Deng, Jian Zhao, Ying Wang, 2020, Stem cell research.

Establishment of an induced pluripotent stem cell (SIAISi016-A) line from a 62-years old Chinese Han patient with Alzheimer's disease.

Yulei Deng, Jian Zhao, Ying Wang, 2023, Stem cell research.

Establishment of SIAISi021-A, an induced pluripotent stem cell (iPSC) line from a 71-year-old Chinese Han male with Alzheimer's Disease (AD) having two copies of APOE4/4 allele.

Yulei Deng, Yanfei Ding, Jian Zhao, 2022, Stem cell research.

Generation of two iPSC cell lines (SIAISi020-A and SIAISi019-A) from an 82-year-old mild cognitive impairment (MCI) and her unaffected child from Chinese Han population.

Yulei Deng, Yanfei Ding, Jian Zhao, 2022, Stem cell research.

Establishment of SIAISi018-A, an induced pluripotent stem cell (iPSC) line from a healthy 45-year-old Chinese Han.

Jian Zhao, Ying Wang, J. Shou, 2022, Stem cell research.

Establishment of SIAISi017-A, an induced pluripotent stem cell(iPSC)line from a healthy 25-year-old Chinese Hui.

Jian Zhao, Ying Wang, J. Shou, 2022, Stem cell research.

Generation of a SIAISi004-A hiPSC line from PBMCs of a 74 year-old Alzheimer's disease woman by non-integrating sendai virus mediated reprogramming.

Jian Zhao, Ying Wang, Weihao Di, 2021, Stem cell research.

Generation of a human induced pluripotent stem cell line (SIAISi010-A) from a 31-year-old healthy donor with Chinese Han genetic background.

Jian Zhao, Ying Wang, Yi Zhang, 2021, Stem cell research.

Generation of a human induced pluripotent stem cell line (SIAISi011-A) from a 61-year-old Chinese Han healthy female donor.

Jian Zhao, Ying Wang, Weihao Di, 2021, Stem cell research.

Generation of three iPSC cell lines (SIAISi006-A, SIAISi007-A and SIAISi008-A) from a 66-year-old Alzheimer's disease (AD) patient and her two unaffected children from Chinese Han population.

Yulei Deng, Jian Zhao, Ying Wang, 2021, Stem cell research.

Establishment of SIAISi001-A, an induced pluripotent stem cell (iPSC) line from 66-year old mild cognitive impairment (MCI) with two copies of APOE4 gene.

Yulei Deng, Yan Yan, Jian Zhao, 2020, Stem cell research.

Establishment of TUSMi007-A, an induced pluripotent stem cell (iPSC) line from an 83-year old Chinese Han patient with Alzheimer's disease (AD).

Jing Zhang, Jian Zhao, Ying Wang, 2018, Stem cell research.

Derivation of induced pluripotent stem cells TUSMi006 from an 87-year old Chinese Han Alzheimer's disease patient carrying GRINB and SORL1 mutations.

Jian Zhao, Ying Wang, Hongxiang Yu, 2018, Stem cell research.

Establishment of TUSMi003-A, an induced pluripotent stem cell (iPSC) line from a 62-year old Chinese Han patient with Alzheimer's disease with ApoE3/4 genetic background.

Jing Zhang, Jian Zhao, Ying Wang, 2018, Stem cell research.

Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.

Zhongmin Liu, Jing Zhang, Jian Zhao, 2017, Stem cell research.

Generation of a human induced pluripotent stem cell line from a 65-year old healthy female donor with Chinese Han genetic background.

Jing Zhang, Jian Zhao, Ying Wang, 2017, Stem cell research.

A new transmyocardial degradable stent combined with growth factor, heparin, and stem cells in acute myocardial infarction.

Cun-xian Song, Xiao-cheng Liu, Qin Yang, 2009, Cardiovascular research.

Transmyocardial drilling revascularization combined with heparinized bFGF-incorporating stent activates resident cardiac stem cells via SDF-1/CXCR4 axis.

Jing Liu, Ye Zhao, T. Gu, 2012, Experimental cell research.